Amphastar Pharmaceuticals (AMPH) News Today $27.35 +0.73 (+2.74%) As of 01:09 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock AMPH Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 Time Period Bridge City Capital LLC Increases Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)Bridge City Capital LLC lifted its position in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) by 65.3% in the 1st quarter, according to its most recent 13F filing with the SEC. The firm owned 115,855 shares of the company's stock after acquiring an additional 45,760 shares duJune 9 at 9:16 AM | marketbeat.comAmphastar Pharmaceuticals director sells $12,835 in stockJune 6, 2025 | investing.comUBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $3.09 Million Stock Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC trimmed its position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) by 85.6% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 83,231 shares of the compaJune 6, 2025 | marketbeat.comAmphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Director Sells $12,835.00 in StockAmphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Get Free Report) Director Floyd F. Petersen sold 500 shares of the business's stock in a transaction that occurred on Monday, June 2nd. The stock was sold at an average price of $25.67, for a total value of $12,835.00. Following the sale, the director now owns 72,909 shares of the company's stock, valued at $1,871,574.03. The trade was a 0.68% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website.June 5, 2025 | marketbeat.comInsider Selling: Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Director Sells 500 Shares of StockJune 5, 2025 | insidertrades.comSquarepoint Ops LLC Buys 11,929 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)Squarepoint Ops LLC grew its stake in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) by 208.0% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 17,664 shares of the company's stock afJune 3, 2025 | marketbeat.comAmphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Short Interest Up 24.9% in MayAmphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Get Free Report) saw a large growth in short interest in May. As of May 15th, there was short interest totalling 4,010,000 shares, a growth of 24.9% from the April 30th total of 3,210,000 shares. Approximately 11.5% of the shares of the company are short sold. Based on an average daily trading volume, of 630,000 shares, the days-to-cover ratio is currently 6.4 days.June 3, 2025 | marketbeat.comNuveen Asset Management LLC Has $3.55 Million Stock Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)Nuveen Asset Management LLC decreased its position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) by 54.0% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 95,665 shares of the company's stock after selling 112,307June 2, 2025 | marketbeat.comVoloridge Investment Management LLC Has $5.33 Million Stock Holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)Voloridge Investment Management LLC lifted its holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) by 16.2% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 143,436 shares of the company's stMay 28, 2025 | marketbeat.comTwo Sigma Advisers LP Decreases Stock Holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)Two Sigma Advisers LP decreased its position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) by 12.6% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 85,900 shares of the company's stock after selling 12,4May 28, 2025 | marketbeat.comMan Group plc Makes New $810,000 Investment in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)Man Group plc bought a new position in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 21,825 shares of the company'sMay 27, 2025 | marketbeat.comDeutsche Bank AG Has $1.27 Million Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)Deutsche Bank AG increased its holdings in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) by 46.6% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 34,082 shares of the company's sMay 27, 2025 | marketbeat.comPoint72 Asset Management L.P. Sells 29,617 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)Point72 Asset Management L.P. trimmed its stake in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) by 76.3% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 9,200 shares of the company's stock afteMay 26, 2025 | marketbeat.comTwinbeech Capital LP Takes $1.74 Million Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)Twinbeech Capital LP purchased a new position in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 46,797 shares of the companyMay 24, 2025 | marketbeat.comBNP Paribas Financial Markets Sells 57,502 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)BNP Paribas Financial Markets reduced its stake in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) by 60.9% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 36,964 shares of the company's stock after selling 57,502 shares during the perioMay 22, 2025 | marketbeat.comSystematic Financial Management LP Acquires Shares of 246,348 Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)Systematic Financial Management LP acquired a new stake in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund acquired 246,348 shares of the company's stockMay 20, 2025 | marketbeat.comJanus Henderson Group PLC Grows Holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)Janus Henderson Group PLC lifted its holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) by 28.8% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 189,347 shares of the company's stock after buyiMay 20, 2025 | marketbeat.comD. E. Shaw & Co. Inc. Boosts Stock Holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)D. E. Shaw & Co. Inc. grew its position in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) by 402.4% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 118,851 shares of thMay 20, 2025 | marketbeat.comJane Street Group LLC Raises Holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)Jane Street Group LLC grew its holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) by 23.0% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 99,487 shares of the company'sMay 15, 2025 | marketbeat.comNorthern Trust Corp Buys 29,808 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)Northern Trust Corp grew its stake in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) by 5.1% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 613,170 shares of the company's stock after acquirMay 15, 2025 | marketbeat.comJPMorgan Chase & Co. Reiterates "Neutral" Rating for Amphastar Pharmaceuticals (NASDAQ:AMPH)JPMorgan Chase & Co. reiterated a "neutral" rating and set a $30.00 price objective (down previously from $45.00) on shares of Amphastar Pharmaceuticals in a research report on Monday.May 14, 2025 | marketbeat.comAmphastar stock rating cut to Neutral by JPMorganMay 14, 2025 | investing.comJP Morgan Downgrades Amphastar Pharmaceuticals (AMPH)May 13, 2025 | msn.comAmphastar Pharmaceuticals: Navigating Through An Inflection YearMay 11, 2025 | seekingalpha.comAmphastar Pharmaceuticals, Inc.: Amphastar Pharmaceuticals to Present at the 2025 Bank of America Health Care ConferenceMay 10, 2025 | finanznachrichten.deAmphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Purchased by Schonfeld Strategic Advisors LLCSchonfeld Strategic Advisors LLC raised its position in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) by 343.6% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 42,614 shares of theMay 9, 2025 | marketbeat.comAmphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Q1 2025 Earnings Call TranscriptMay 8, 2025 | insidermonkey.comAmphastar outlines key launches and product growth drivers for 2025May 8, 2025 | msn.comAmphastar Pharmaceuticals (NASDAQ:AMPH) Misses Q1 Sales TargetsMay 7, 2025 | msn.comAmphastar Pharmaceuticals (NASDAQ:AMPH) Misses Q1 Sales TargetsMay 7, 2025 | msn.comAmphastar Pharmaceuticals (AMPH) Reports Earnings Tomorrow: What To ExpectMay 6, 2025 | finance.yahoo.comDimensional Fund Advisors LP Buys 105,288 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)Dimensional Fund Advisors LP boosted its stake in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) by 9.6% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 1,198,590 shares of the company's stock after purchasiMay 6, 2025 | marketbeat.comFirst Trust Advisors LP Raises Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)First Trust Advisors LP lifted its stake in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) by 350.0% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 81,129 shares of the company's stoMay 6, 2025 | marketbeat.comAristeia Capital L.L.C. Acquires Shares of 43,235 Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)Aristeia Capital L.L.C. acquired a new position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor acquired 43,235 shares of theMay 5, 2025 | marketbeat.comAmphastar Pharmaceuticals (AMPH) Projected to Post Quarterly Earnings on WednesdayAmphastar Pharmaceuticals (NASDAQ:AMPH) will be releasing its Q1 2025 earnings after the market closes on Wednesday, May 7. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-7-amphastar-pharmaceuticals-inc-stock/)May 4, 2025 | marketbeat.comAmphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Director Sells $12,040.00 in StockMay 3, 2025 | insidertrades.comBarclays PLC Buys 10,334 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)Barclays PLC grew its stake in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) by 13.9% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 84,790 shares of the company's stock after acquiring anMay 2, 2025 | marketbeat.comRaymond James Financial Inc. Invests $3.45 Million in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)Raymond James Financial Inc. purchased a new stake in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund purchased 92,904 shares of the company's stock, valued at approximately $3,450,000. RayApril 29, 2025 | marketbeat.comAmphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Purchased by Oberweis Asset Management Inc.Oberweis Asset Management Inc. raised its position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) by 14.5% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 184,595 shares of the company's stock after purchaApril 27, 2025 | marketbeat.comFuller & Thaler Asset Management Inc. Sells 127,841 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)Fuller & Thaler Asset Management Inc. trimmed its stake in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) by 10.1% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 1,132,926 shares of the company's stock aftApril 26, 2025 | marketbeat.com2 Safe-and-Steady Stocks with Solid Fundamentals and 1 to Think Twice AboutApril 24, 2025 | finance.yahoo.comBank of America Securities Remains a Hold on Amphastar Pharmaceuticals (AMPH)April 22, 2025 | markets.businessinsider.comAmphastar price target lowered to $31 from $36 at BofAApril 22, 2025 | markets.businessinsider.comMesirow Institutional Investment Management Inc. Has $14.12 Million Holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)Mesirow Institutional Investment Management Inc. trimmed its stake in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) by 8.1% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 380,389 shares of the companApril 22, 2025 | marketbeat.comAmphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Position Decreased by Epoch Investment Partners Inc.Epoch Investment Partners Inc. reduced its holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) by 7.5% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,101,273 shares of the compApril 22, 2025 | marketbeat.comMarshall Wace LLP Buys 40,212 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)Marshall Wace LLP lifted its stake in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) by 7.1% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 608,706 shares of the company's stock after purchasing an additional 40,April 22, 2025 | marketbeat.comJPMorgan Chase & Co. Sells 385,349 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)JPMorgan Chase & Co. lowered its holdings in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) by 71.5% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 153,571 shares of the company'sApril 21, 2025 | marketbeat.comAmphastar Pharmaceuticals (NASDAQ:AMPH) Sets New 1-Year Low - Should You Sell?Amphastar Pharmaceuticals (NASDAQ:AMPH) Hits New 1-Year Low - Here's What HappenedApril 18, 2025 | marketbeat.comAmphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Sold by LSV Asset ManagementLSV Asset Management lowered its position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) by 54.7% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 36,400 shares of the company's stock after selling 44,0April 17, 2025 | marketbeat.comPortolan Capital Management LLC Cuts Stock Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)Portolan Capital Management LLC trimmed its holdings in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) by 60.0% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 131,123 shares of the company'April 16, 2025 | marketbeat.com Get Amphastar Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for AMPH and its competitors with MarketBeat's FREE daily newsletter. Email Address AMPH Media Mentions By Week AMPH Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AMPH News Sentiment▼1.070.68▲Average Medical News Sentiment AMPH News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AMPH Articles This Week▼74▲AMPH Articles Average Week Get Amphastar Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for AMPH and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies PCVX News Today MRUS News Today RYTM News Today AKRO News Today RNA News Today PTCT News Today CYTK News Today SRPT News Today KRYS News Today ACAD News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AMPH) was last updated on 6/10/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredWhy 2026 will be a disaster for many Americans2025 Market Crash The first-quarter stock crash left investors wondering what lies ahead. Today 50-year Wal...Chaikin Analytics | SponsoredTrump’s treachery This might just be the greatest time in America to be an energy company. Since taking office in 2025, Presi...Porter & Company | SponsoredBig Changes Coming to Social Security?According to legendary investor Louis Navellier... This new Trump move could soon not only save Social Secu...InvestorPlace | SponsoredSHOCKING: Musk's Pentagon Secret Mission...It's about a harrowing message discovered on December 16, 2024: "美国军方暗杀名单" It's the reason President Tru...Behind the Markets | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Amphastar Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Amphastar Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy AMPH Stock Free AMPH Stock Alerts